ID   KN-41
AC   CVCL_W215
SY   KN41
DR   Wikidata; Q54900238
RX   PubMed=4087630;
RX   PubMed=6620776;
RX   PubMed=7154478;
RX   PubMed=10929426;
CC   Population: Japanese.
CC   Doubling time: 20.9 hours (PubMed=7154478).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
RX   PubMed=4087630; DOI=10.5980/jpnjurol1928.76.9_1368;
RA   Nishino A.;
RT   "Studies of cytofluorometric DNA determination and chemosensitivity of
RT   KN-41 renal cancer cells in exponential and plateau phases.";
RL   Nihon Hinyokika Gakkai Zasshi 76:1368-1380(1985).
//
RX   PubMed=6620776; DOI=10.5980/jpnjurol1928.74.5_704;
RA   Koizumi H.;
RT   "Chemosensitivity of KK-47 bladder cancer cells and KN-41 renal cancer
RT   cells heterotransplanted in nude mice.";
RL   Nihon Hinyokika Gakkai Zasshi 74:704-718(1983).
//
RX   PubMed=7154478; DOI=10.5980/jpnjurol1928.73.8_1019;
RA   Naito K., Hisazumi H., Kanokogi M., Katoh M., Nakazima K.,
RA   Tsukahara K., Kobayashi T., Kuroda K., Matsubara F.;
RT   "Establishment of cell lines (KH-39, KN-41, and KW-103) from human
RT   kidney and bladder cancer and their characteristics.";
RL   Nihon Hinyokika Gakkai Zasshi 73:1019-1031(1982).
//
RX   PubMed=10929426; DOI=10.1007/s002400000103;
RA   Shintaku I., Kawagoe N., Yutani S., Hoshi S., Orikasa S.,
RA   Yoshizumi O., Itoh K.;
RT   "Expression of the SART1 tumor rejection antigen in renal cell
RT   carcinoma.";
RL   Urol. Res. 28:178-184(2000).
//